Search research articles
Contact Us
Filters
Showing results (91-100 of 140) with videos related to
Page
of 14
Sort By:
Journal of Medicinal Chemistry
|
November 11, 2005
Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide
Gabriele Murineddu, Stefania Ruiu, Giovanni Loriga, et al.
European Heart Journal
|
June 27, 2015
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database
Gian Paolo Fadini, Angelo Avogaro, Luca Degli Esposti, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 29, 2003
Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor
Stefania Ruiu, Gèrard A Pinna, Giorgio Marchese, et al.
Journal of Neuroscience Research
|
July 30, 2024
Behavioral and transcriptional effects of carnosine in the central ring ganglia of the pond snail Lymnaea stagnalis
Veronica Rivi, Giuseppe Caruso, Filippo Caraci, et al.
NPJ Digital Medicine
|
December 8, 2025
Explainable AI-driven precision clinical trial enrichment: demonstration of the NetraAI platform with a phase II depression trial
Joseph Geraci, Bessi Qorri, Mike Tsay, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Joseph Geraci, Patrick P O'Keefe, Bessi Qorri, et al.
International Immunopharmacology
|
March 16, 2025
Unraveling lipopolysaccharide-induced behavioral and molecular effects in Lymnaea stagnalis, an emerging model organism for translational neuroscience
Veronica Rivi, Giovanna Rigillo, Silvia Alboni, et al.
The Journal of Clinical Psychiatry
|
May 20, 2024
Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017)
Clotilde Guidetti, Sara De Martin, Giulia Serra, et al.
Neuroscience Applied
|
April 10, 2026
Application of the research domain criteria in early-phase clinical development of transdiagnostic neurotherapeutics: A multidisciplinary perspective
Igor Magaraggia, Franco Di Cesare, Jordi Alonso, et al.
The Primary Care Companion for CNS Disorders
|
February 23, 2023
Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive Disorder
Clotilde Guidetti, Giulia Serra, Luca Pani, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 140) with videos related to
Sort By:
Page
of 14
Journal of Medicinal Chemistry
|
November 11, 2005
Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide
Gabriele Murineddu, Stefania Ruiu, Giovanni Loriga, et al.
European Heart Journal
|
June 27, 2015
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database
Gian Paolo Fadini, Angelo Avogaro, Luca Degli Esposti, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 29, 2003
Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor
Stefania Ruiu, Gèrard A Pinna, Giorgio Marchese, et al.
Journal of Neuroscience Research
|
July 30, 2024
Behavioral and transcriptional effects of carnosine in the central ring ganglia of the pond snail Lymnaea stagnalis
Veronica Rivi, Giuseppe Caruso, Filippo Caraci, et al.
NPJ Digital Medicine
|
December 8, 2025
Explainable AI-driven precision clinical trial enrichment: demonstration of the NetraAI platform with a phase II depression trial
Joseph Geraci, Bessi Qorri, Mike Tsay, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Joseph Geraci, Patrick P O'Keefe, Bessi Qorri, et al.
International Immunopharmacology
|
March 16, 2025
Unraveling lipopolysaccharide-induced behavioral and molecular effects in Lymnaea stagnalis, an emerging model organism for translational neuroscience
Veronica Rivi, Giovanna Rigillo, Silvia Alboni, et al.
The Journal of Clinical Psychiatry
|
May 20, 2024
Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017)
Clotilde Guidetti, Sara De Martin, Giulia Serra, et al.
Neuroscience Applied
|
April 10, 2026
Application of the research domain criteria in early-phase clinical development of transdiagnostic neurotherapeutics: A multidisciplinary perspective
Igor Magaraggia, Franco Di Cesare, Jordi Alonso, et al.
The Primary Care Companion for CNS Disorders
|
February 23, 2023
Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive Disorder
Clotilde Guidetti, Giulia Serra, Luca Pani, et al.
Page
of 14